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The cytosolic Ca2+-binding protein regucalcin is involved in intracellular signaling and present in high abundance in the liver. Here, we could
show by comparative mass spectrometry-based proteomics screening of normal versus dystrophic fibres that regucalcin of 33.9 kDa and pI5.2 also
exists in diaphragm muscle. Since the expression of sarcolemmal Ca2+-leak channels and luminal Ca2+-binding elements is altered in dystrophin-
deficient muscle, we initiated this study in order to determine whether additional soluble muscle proteins involved in Ca2+-handling are affected in
muscular dystrophy. Following separation by two-dimensional gel electrophoresis, the spot pattern of the normal versus the mdx diaphragm
muscle proteome was evaluated by densitometry. The expression levels of 20 major protein spots were shown to change and their identity
determined by mass spectrometry. A 2-fold reduction of regucalcin in mdx diaphragm, as well as in dystrophic limb muscle and heart, was
confirmed by immunoblotting in both young and aged mdx mice. The results from our proteomics analysis of dystrophic diaphragm support the
concept that abnormal Ca2+-handling is involved in x-linked muscular dystrophy. The reduction in key Ca2+-handling proteins may result in an
insufficient maintenance of Ca2+-homeostasis and an abnormal regulation of Ca2+-dependent enzymes resulting in disturbed intracellular signaling
mechanisms in dystrophinopathies.
© 2006 Elsevier B.V. All rights reserved.Keywords: mdx diaphragm; Calcium homeostasis; Regucalcin; Muscle proteomics; Muscular dystrophy1. Introduction
A primary deficiency in the Dp427 isoform of the membrane
cytoskeletal protein dystrophin leads to a progressive muscle
wasting process [1], making Duchenne muscular dystrophy the
most frequent neuromuscular disorder in humans [2]. On the
molecular level, deficiency in full-length dystrophin triggers the
loss of a subset of surface proteins [3], including dystroglycans,
sarcoglycans, sarcospan, syntrophins, dystrobrevins and asso-
ciated signaling elements such as neuronal nitric oxide synthase
[4–7]. In normal muscle fibres, the dystrophin-associated
glycoprotein complex is thought to stabilize the fibre periphery
by providing a linkage between the actin membrane cytoskel-
eton and the extracellular matrix component laminin [8]. When
dystrophin is missing, this trans-sarcolemmal connection is⁎ Corresponding author. Tel.: +353 1 708 3842; fax: +353 1 708 3845.
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doi:10.1016/j.bbapap.2006.01.007impaired [9], resulting in an increased frequency of surface
micro-rupturing [10]. During the natural membrane re-sealing
process, Ca2+-leak channels are introduced into the dystrophic
sarcolemma [11] causing elevated cytosolic Ca2+-levels that
will eventually render muscle fibres more susceptible to
necrosis [12]. It is not known how many pathophysiological
steps are involved in this process, nor the nature of the hierarchy
in the down-stream events leading to fibre degeneration [13,14],
but it has been established that the physiological function of
various ion-handling proteins [15–18] and excitation–contrac-
tion coupling elements [19,20] is impaired in x-linked muscular
dystrophy.
Novel strategies for the large-scale analysis of differential
gene expression and protein expression profiling of a
particular cell type are represented by high-throughput
transcriptomics and proteomics screening [21,22]. Both
approaches have been applied to the study of muscular
dystrophies using comparative transcriptomics [23–27] and
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give new insight into the molecular pathogenesis of these
devastating disorders [30,31]. Proteomics is the qualitative and
quantitative comparison of proteomes under varying biological
conditions [32]. The muscle proteome can be defined as the
protein complement expressed by a given muscle fibre genome
[33]. Mass spectrometry-based proteomics has been successful-
ly applied to the cataloguing of muscle proteins [34,35], the
identification of age-dependent protein nitration [36], the
analysis of O-linked N-acetylglucosamine proteins [37], the
determination of fibre type-specific differences [38], the analysis
of stimulation-induced changes in transforming muscle [39] and
the expression profiling during muscle growth [40,41]. Recent
studies employing proteomics technology to identify biomarkers
in muscular dystrophy have focused on the soluble subproteome
and the Ca2+-binding protein subproteome and could show that
the expression of important proteins such as adenylate kinase
and calsequestrin are greatly reduced in dystrophin-deficient
fibres [17,28]. However, these investigations were performed
with limb muscle specimens from the mdx mouse that exhibit a
relatively mild dystrophic phenotype as compared to the
seriously affected muscle fibres from Duchenne muscular
dystrophy patients.
In contrast to mdx limb muscles, the murine x-linked
dystrophic diaphragm shows severe symptoms of skeletal
muscle fibre degeneration that is more comparable to Duchenne
muscular dystrophy [42]. This makes the mdx mouse
diaphragm, which is missing dystrophin due to a point mutation
[43], a highly suitable animal model for studying pathobio-
chemical and pathophysiological changes during fibre degen-
eration [44,45]. We therefore employed total diaphragm extracts
to investigate the differential proteome expression pattern of
normal versus dystrophic muscle fibres. Following two-
dimensional gel electrophoretic separation, the protein spot
pattern was evaluated with 2D analysis software and protein
species with a drastically changed expression level were
identified via mass spectrometric fingerprinting. The proteo-
mics approach demonstrated a drastic decrease of a protein
named regucalcin [46] in the mdx diaphragm, which was
confirmed by immunoblotting. Regucalcin has not previously
been identified in diaphragm tissue and was originally described
by Yamaguchi and Yamamoto [47] in rat liver cytosol and
shown to regulate the activity of numerous Ca2+/calmodulin-
dependent enzymes [48]. Since regucalcin represents an
important Ca2+-handling protein that is involved in various
intracellular signaling mechanisms [49–51], its abnormal
expression in dystrophin-deficient muscle agrees with the
calcium hypothesis of muscular dystrophy that assumes that
abnormal ion cycling plays a central role in skeletal muscle fibre
degeneration [13].
2. Materials and methods
2.1. Materials
Electrophoresis grade chemicals, PhastGel Coomassie Blue R-350 tablets,
silver staining kit, fluorescent Deep Purple stain, immobilized pH gradient (IPG)
strips of pH 3–10 (linear) and IPG buffer of pH 3–10 for isoelectric focusing, the2D-Quant kit for determination of protein concentration in electrophoretic
samples, the 2D-Clean-Up kit for removal of contaminants prior to isoelectric
focusing, and acetonitrile were purchased from Amersham Biosciences/GE
Healthcare (Little Chalfont, Buckinghamshire, UK). A matrix kit containing α-
cyano-4-hydroxycinnamic acid was obtained from Laserbiolabs, Sophia-
Antipolis, France. DNase-I enzyme was from Sigma Chemical Company,
Dorset, UK and sequencing grade-modified trypsin was from Promega
(Madison, WI, USA). For desalting of MS samples, C-18 Zip-Tips were
purchased from Millipore Ireland B.V. (Carrigtwohill, Co. Cork, Ireland).
Ultrapure Protogel acrylamide stock solutions were obtained from National
Diagnostics (Atlanta, GA, USA). Primary antibodies were purchased from Cell
Sciences, Canton, MA, USA (mAb HM3018 to regucalcin), Affinity
Bioreagents, Golden, CO, USA (mAb VIIID12 to the fast CSQf isoform of
calsequestrin, mAb XIIC4 to sarcalumenin, and mAb 20A to the α2-subunit of
the dihydropyridine receptor), Novacastra Laboratories Ltd., Newcastle upon
Tyne, UK (mAb NCL-DYS1 against the Dp427 isoform of dystrophin, and mAb
NCL-43 to β-dystroglycan), and Upstate Biotechnology Lake Placid, NY, USA
(mAb C464.6 to the α1-subunit of the Na
+/K+-ATPase, and mAb VIA41 to α-
dystroglycan). Peroxidase-conjugated secondary antibodies were obtained from
Chemicon International, Temecula, CA USA. Immobilon NC nitrocellulose
membranes, chemiluminescence substrates and protease inhibitors were
purchased from Millipore, Bedford, MA, USA, Pierce and Warriner, Chester,
UK, and Roche Diagnostics GmbH, Mannheim, Germany, respectively. All
other chemicals used were of analytical grade and purchased from Sigma
Chemical Company, Dorset, UK.
2.2. Animal model of muscular dystrophy
Primary deficiency in the Dp427 isoform of the membrane cytoskeletal
protein dystrophin characterizes the mdx animal model of Duchenne muscular
dystrophy, which is due to a point mutation in exon 23 [43]. As with most animal
models, the mdx mouse does not represent a perfect replica of the human
pathology. However, dystrophic mdx fibres, especially those of the diaphragm
[42], show many of the secondary abnormalities observed in Duchenne
muscular dystrophy. This includes elevated levels of serum creatine kinase, a
dramatic reduction in the dystrophin-associated glycoprotein complex,
abnormal excitation–contraction coupling and segmental fibre necrosis, as
well as an increased susceptibility to osmotic shock and stretch-induced injury
[45]. Thus, the mdx diaphragm is a suitable mouse model system for studying
the most frequent x-linked neuromuscular disorder in humans. Male mice of the
Dmdmdx strain (Jackson Laboratory, Bar Harbor, Maine) of varying age and age-
matched C57 controls were obtained through the Biomedical Facility of the
National University of Ireland, Maynooth. For proteomics screening, the entire
diaphragm muscle (∼100 mg wet weight) was dissected from control C57 mice
and mdx mice. The animal population used in this study consisted of 25 normal
and 25 dystrophic mice and tissue samples were used for the initial optimization
of experimental procedures and the subsequent detailed biochemical analyses.
According to international standards of difference gel electrophoresis, seven
control and seven dystrophic samples were used for the statistical analysis of the
electrophoretically separated muscle proteome.
2.3. Preparation of muscle protein extracts
Equal amounts of normal and dystrophic diaphragm, limb muscle or heart
tissue were quick-frozen in liquid nitrogen and ground up into a fine powder
using a pestle and mortar. Subsequently, the muscle tissue powder was
resuspended in 1 ml of lysis buffer (9.5 M Urea, 4% (w/v) Chaps, 0.5%
ampholytes pH 3–10, 100 mMDTT). To avoid protein degradation, the solution
was supplemented with a freshly prepared protease inhibitor cocktail, consisting
of 0.2 mM pefabloc, 1.4 μM pepstatin, 0.15 μM aprotinin, 0.3 μM E-64, 1 μM
leupetin, 0.5 mM soybean trypsin inhibitor and 1 mMEDTA [17]. In addition, to
eliminate excessive viscosity of the total muscle extract due to the presence of
DNA, 2 μl of DNase-I (200 units) were added per 100 μl of extraction buffer
[39]. After incubation for 3 h at room temperature, with gentle vortexing every
10 min for 30 s, the suspension was centrifuged at 4 °C for 20 min at 20,000×g
using a 5417R centrifuge from Eppendorf (Hamburg, Germany). The middle
layer containing the extracted muscle proteins was carefully removed and a
portion of it was saved for the determination of protein concentration using the
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Buckinghamshire, UK). Protein extracts from normal and dystrophic diaphragm
were immediately used for electrophoretic separation or stored at −70 °C in 200
μg protein aliquots until further processing.
2.4. Two-dimensional gel electrophoresis
In order to improve the quality of the two-dimensional separation of muscle
proteins, interfering contaminants, such as lipids, salts and nucleic acids, were
removed prior to isoelectric focusing, using the 2D-Clean-Up kit from
Amersham Biosciences/GE Healthcare (Little Chalfont, Buckinghamshire,
UK) as described by the manufacturer. Precipitated muscle proteins were
resuspended in IEF rehydration buffer (9.5 M Urea, 4% (w/v) Chaps, 0.5%
ampholytes pH 3–10 and 100 mM DTT) and resuspended by gentle vortexing
and pipetting, and then subjected to ultra sonnication. Sample tubes were
placed in a beaker of ice-cold water to avoid carbamylation of proteins, which
may alter the pI of the protein thereby producing artefactual charge trains of
proteins across the first-dimension gel. The ultra sonnicator (Bandelin
Sonoplus Model HD-2200 with an MS-72 probe; Bandelin Electronic
GmbH, Berlin, Germany) was set at a low setting of 15%, whereby
sonnication was gradually increased. Samples were sonicated for 20 s with a
1-min cooling-off period, and this procedure was repeated 5 times. Samples
were pelleted in a benchtop centrifuge for 30 s at 2000×g and then isoelectric
focusing was performed using an IPGphor focusing system from Amersham
Biosciences/GE Healthcare (Little Chalfont, Buckinghamshire, UK), with 13
cm IPG strips of pH 3–10 (linear) and 50 μA per strip. Total muscle protein
extracts were diluted in the above described rehydration buffer (complemented
with 0.05% (w/v) bromophenol blue as a tracking dye) to achieve a final
protein concentration of 200 μg of protein per IPG strip. The following running
conditions were used: 60 min at 100 V, 60 min at 500 V, 60 min at 1000 V, 60
min at 2000 V, 60 min at 4000 V, 60 min at 6000 V, and finally 150 min at
8000 V [17,39]. Electrophoretic separation in the second dimension, as well as
standard 1D gel electrophoresis, was performed with a 12% resolving SDS-
PAGE slab gel [52] using the Protean Xi-II cell from Bio-Rad Laboratories
(Hemel Hemstead, Hert., UK). Prior to the 2D slab gel step, IPG strips were
equilibrated for 10 min each in equilibration buffer (30% (w/v) glycerol, 20%
(w/v) sucrose, 3% (w/v) SDS, 50 mM Tris–HCl, pH 8.8) containing 100 mM
DTT and equilibration buffer supplemented with 0.25 M ideoacetamide,
respectively. Following brief washing in SDS running buffer, IEF strips were
positioned on top of the second-dimension gel with the help of a 1% (w/v)
agarose sealing gel, poured on top of the strip and left to solidify. Slab gels
were run at a constant voltage of 100 V for 1 h, followed by 300 V for 3 h and
a final electrophoretic step of 500 V for 2 h.
2.5. Protein visualization and image analysis
After completion of the second dimension electrophoretic separation step,
slab gels were stained with Hot Coomassie Brilliant Blue R-350. Alternatively,
gels were stained with the fluorescent dye Deep Purple or Silver [17]. In
contrast to silver staining, as applied in our previous study on the mdx hind
limb muscle [17], in our experience Hot Coomassie staining has more
compatibility with the MALDI-ToF MS peptide mass fingerprinting procedure
for the identification of muscle protein species [39]. The hot Coomassie
solution was made by dissolving one PhastGel Coomassie Blue tablet from
Amersham Biosciences in 1.6 l of 10% (v/v) acetic acid to give a 0.025% (w/v)
staining solution. The solution was slowly heated to 90 °C in a fume hood and
poured over the gel in a stainless steal tray. The tray was placed on top of a hot
plate and the temperature was maintained for 5 min to aid staining of muscle
proteins. The tray was then placed on a laboratory shaker for a further 10 min
at room temperature. Destaining of the gel was achieved by placing it in a 10%
(v/v) acetic acid solution and gentle rocking over night. Small piece of tissue
paper was placed in the tray to soak up excess Coomassie dye and aid in the
destaining process prior to densitometric analysis. Destained gels were
processed immediately or were stored in a plastic folder with 10 ml of a 1%
(v/v) acetic acid solution and were kept at 4 °C until further use. For
comparative proteomics, seven gels each from normal and mdx diaphragm
were densitometrically evaluated using an Imagescanner II from Amersham
Biosciences/GE Healthcare (Little Chalfont, Buckinghamshire, UK). Theprotein level of each 2D spot was expressed as a percentage of total spot
volume in the whole gel. Image analysis was performed with Imagemaster 2-D
Platinium Version 5.0 software (Amersham Biosciences/GE Healthcare, Little
Chalfont, Buckinghamshire, UK).
2.6. Sample preparation for mass spectrometry
Prior to preparation for in-gel digestion, slab gels were washed twice for 10
min with deionized water and then Coomassie-stained spots of interest were
excised using a blue 1 ml pipette tip which top had been cut off to aid in the
smooth transfer of gel plugs. Subsequently, excised gel plugs were placed in
1.5 ml Eppendorf tubes that had been pre-siliconized with Sigmacote (Sigma
Chemical Company, Dorset, UK), and were then destained, desalted and
washed as follows: Gel plugs were first washed with 50% (v/v) acetonitrile/
0.1% (w/v) NH4HCO3 for 15 min. All remaining liquid above the gel plugs
was removed and then sufficient amounts of acetonitrile were added to cover
the gel plugs. Acetonitrile was removed following shrinkage of gel plugs and
then rehydration was carried out for 5 min in a minimum volume of 50 mM
NH4HCO3. An equal volume of acetonitrile was added and after 15 min of
incubation all the liquid was removed and the protein-containing gel plugs
were shrunk in acetonitrile. Following removal of acetonitrile, the gel plugs
were dried down for 30 min using a Heto type vacuum centrifuge from Jouan
Nordic A/S (Allerod, Denmark). Rehydration of individual gel pieces was then
accomplished by adding sufficient amounts of digestion buffer (1 μg of trypsin
in 20 μl of 50 mM NH4HCO3) in order to cover the gel plugs [39].
Sequencing-grade trypsin was obtained from Promega (Madison, WI, USA).
More digestion buffer was added if all the initial volume had been absorbed by
the gel pieces. The samples were then incubated at 37 °C for 60 min. Excess
enzyme solution was removed and approximately 3 μl of 50 mM NH4HCO3
was added to each gel plug in order to keep gel pieces wet overnight.
Following exhaustive digestion overnight at 37 °C, samples were centrifuged
at 12,000×g for 10 min using a model 5417R bench top centrifuged from
Eppendorf (Hamburg, Germany). The supernatant was carefully removed from
each tube and placed into a clean and siliconized plastic tubes. The resulting
peptides were extracted by three sequential extraction steps each of 30 min
duration and a volume of 40 μl each. The solvent of the first extraction
consisted of 50% (v/v) acetonitrile/0.1% (v/v) trifluoroacetic acid. Extraction
was aided by sonication in a Branson-3510 water bath (Branson Ultrasonic
Corporation, Danbury, CT, USA) for 30 min. Samples were the spun down for
30 s at 2000×g. The solvents for the two remaining extraction steps were 60%
(v/v) acetonitrile/0.1% (v/v) trifluoroacetic acid and 80% (v/v) acetonitrile/
0.1% (v/v) trifluoroacetic acid. The solutions from the three separate extraction
procedures were combined and concentrated in a vacuum centrifuge as
described above. Peptide preparations resulting from the processing of
individual gel plugs were resuspended in 8 μl of 3% (v/v) trifluoroacetic
acid and stored at −70 °C until analysed by mass spectrometry.
2.7. MALDI-ToF mass spectrometric analysis
Matrix-assisted laser desorption ionization time-of-flight (MALDI-ToF)
tryptic peptide mass fingerprinting of in-gel digests from normal versus
dystrophic muscle protein species was conducted as previously described
[17,39]. Tryptic peptides from individual samples were desalted using C-18
Zip-Tips (Millipore, Carrigtwohill, Co. Cork, Ireland) and eluted onto the
sample plate with the matrix solution (5 mg/ml α-cyano-4 hydroxycinnamic
acid in 50% (v/v) acetonitrile/0.1% (v/v) trifluoroacetic). Mass spectra were
recorded using an Ettan MALDI-ToF Pro instrument from Amersham
Biosciences (Little Chalfont, Buckinghamshire, UK) operating in the positive
reflector mode at the following parameters: accelerating voltage 20 kV; and
pulsed extraction: on (focus mass 2500). Standard peaks of angiotensin III
(897.5 m/z) and ACTH (2465.19 m/z) and trypsin autolysis peaks at m/z 842.50
and m/z 2211.104 were used for internal calibration [39]. MALDI evaluation
software (Amersham Biosciences/GE Healthcare, Little Chalfont, Buckingham-
shire, UK) was used for the analysis of mass spectra and protein identification
was achieved with the PMF ProFound search engine for peptide mass
fingerprints. All certainty hits of diaphragm muscle proteins generated by the
ProFound search engine were matched against the publicly available search
engine Mascot (http://www.matrixscience.com).
Fig. 1. One-dimensional immunoblot analysis of luminal Ca2+-binding proteins
in mdx diaphragm. Shown are identical 1D immunoblots labelled with
antibodies to the Dp427 isoform of dystrophin (A), the α2-subunit of the
dihydropyridine receptor (DHPR; B), α-dystroglycan (α-DG; C), β-dystrogly-
can (β-DG; D), the fast CSQf isoform of calsequestrin (E), and sarcalumenin
(SAR; F). Lanes 1 and 2 represent total protein extracts from normal and
dystrophic mdx diaphragm muscle fibres, respectively.
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Electrophoretic transfer of proteins to Immobilin NC-pure nitrocellulose
membranes was carried out according to Towbin et al. [53] using a Bio-Rad
Transblot cell (Bio-Rad Labs., Hemel Hempstead, Herts., U.K.). Proteins were
transferred at 4 °C for 80 min at 100 V. Efficiency of transfer was evaluated by
Ponceau-S-Red staining of nitrocellulose membranes, followed by destaining in
phosphate buffered saline (PBS; 50 mM sodium phosphate, 0.9% (w/v) NaCl,
pH 7.4). Membranes were blocked for 1 h in 5% (w/v) fat-free milk powder in
PBS. Membranes were then incubated for 3 h at room temperature with primary
antibody, appropriately diluted with blocking buffer. Nitrocellulose replicas
were subsequently twice washed for 10 min in blocking solution and then
incubated with an appropriate dilution of the corresponding peroxidase-
conjugated secondary antibodies for 1 h at room temperature. Nitrocellulose
membranes were washed twice for 10 min in blocking solution and twice rinsed
for 10 min in PBS. Visualization of immuno-decorated 1D bands or 2D spots
was carried out with the SuperSignal enhanced chemiluminescence kit from
Pierce and Warriner (Chester, Cheshire, U.K.) [54]. Densitometric scanning of
immunoblots was performed on a Molecular Dynamics 300S computing
densitometer (Sunnyvale, CA, USA) with Imagequant V3.0 software.
3. Results
Dystrophin-deficient muscle fibres exhibit abnormal excita-
tion–contraction coupling and impaired Ca2+-handling. Here,
we have used mass spectrometry-based proteomics and two-
dimensional immunoblotting in order to determine whether the
expression of novel Ca2+-binding elements is affected in x-
linked muscular dystrophy. Since the diaphragm from the mdx
mouse model of Duchenne muscular dystrophy is a severely
affected type of muscle, total diaphragm extracts rather than
hind limb muscle preparations were used to evaluate the
differential proteome expression pattern of normal versus
dystrophic muscle fibres.
3.1. Reduced expression of luminal Ca2+-binding proteins in
dystrophic diaphragm
In analogy to the established finding that the luminal Ca2+-
binding proteins calsequestrin and sarcalumenin are reduced in
dystrophic mdx hind limb muscle preparations [16,17], we can
show here that the expression of both sarcoplasmic reticulum
components is also affected in the mdx diaphragm. Our initial
1D immunoblotting survey illustrated that deficiency in the
dystrophin isoform Dp427 (Fig. 1A) is associated with a drastic
reduction in α/β-dystroglycan (Fig. 1C, D), the Ca2+-binding
protein calsequestrin of the terminal cisternae region (Fig. 1E)
and the Ca2+-shuttle element sarcalumenin of the longitudinal
tubules (Fig. 1F). Thus, the two most abundant luminal Ca2+-
reservoir proteins that occupy a central position in the
regulatory apparatus of the excitation–contraction–relaxation
cycle of skeletal muscle are severely reduced in the dystrophic
diaphragm. In two-dimensional gels of total diaphragm extracts,
as shown below in Fig. 2, distinct spots did not correlate with
the isoelectric point and molecular mass of these two essential
Ca2+-binding proteins of apparent 63 kDa and 160 kDa. The
relative density of luminal components of the sarcoplasmic
reticulum appears to be too low for proper representation by
protein dye-staining, following extraction, isoelectric focusing
and slab gel electrophoresis of total muscle preparations. Incontrast to the reduced density of calsequestrin and sarcalume-
nin in mdx diaphragm, the auxiliary α2-subunit of the voltage-
sensing dihydropyridine receptor from the transverse tubules
was shown to exhibit very comparable expression levels in
normal versus dystrophic diaphragm (Fig. 1B). This agrees with
previous findings from mdx hind limb preparations and
demonstrates equal loading of normal versus dystrophic
diaphragm fractions in individual gel lanes.
3.2. Comparative two-dimensional gel electrophoresis of
normal versus mdx diaphragm
Mouse skeletal muscle is a highly complex and specialized
mammalian tissue that contains a considerable amount of
insoluble protein species and approximately half of its protein
components constitute the contractile apparatus. These biolog-
ical facts make it more difficult to separate crude muscle
extracts in two-dimensional gels, as compared, for example, to
bacterial preparations, and therefore necessitated initial optimi-
zation experiments. Following electrophoretic trials with
varying amounts of protein (not shown), the optimum amount
of diaphragm muscle protein per isoelectric focusing strip was
found to be approximately 200 μg in order to perform a
comparative proteomics approach. A lower protein concentra-
tion led to minimal cross-contamination between individual
protein species, but resulted in a weak staining pattern. A higher
Fig. 2. Two-dimensional gel electrophoretic comparison between normal and mdx diaphragm muscle extracts. Shown are Hot Coomassie-stained 2D gels of total
protein extracts from normal (A) and dystrophic mdx (B) diaphragmmuscle. The pH-values of the first dimension gel system and molecular mass standards (in kDa) of
the second dimension are indicated on the top and on the left of the panels, respectively.
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probably due to artefactual charge trains of proteins in the first
dimension and spot smearing caused by abnormal electropho-
retic mobility of abundant protein species in the second
dimension. Thus, although it is possible to load a considerably
higher concentration of protein per first dimension gel, in our
experience cross-contamination of the two-dimensional spot
pattern with abundant muscle proteins such as myosin, actin,
troponin and tropomyosin prevents an approach with more
than 200 μg protein when using mouse diaphragm muscle
preparations.
Fig. 2 shows representative two-dimensional gels of the
normal C57 mouse diaphragm proteome versus the dystrophic
mdx diaphragm proteome. Gel labelling using silver (not
shown) or the fluorescent Amersham dye Deep Purple (see
below) revealed similar protein patterns. However, in our
experience Hot Coomassie staining is the most compatible
protein staining method for a subsequent mass spectrometric
analysis and is therefore shown here. Well-established muscle
marker proteins ranging from 16.1 kDa (superoxide dismutase)
to 223.7 kDa (myosin β-heavy chain) in relative molecular
mass and with a pI-range of approximately pH 4.1 (troponin C)
to pH 9.2 (isocitrate dehydrogenase) could be separated. See
below for the identification of these proteins by MALDI-ToF
MS tryptic peptide mass fingerprinting from in-gel digests. The
overall two-dimensional spot pattern of the gels shown in Fig.
2A, B is comparable to published studies on the electrophoretic
separation of total skeletal muscle extracts [34,35] and agrees
with international data banks, such as the SWISS-2DPAGE
database (http://www.us.expasy.org/ch2d/). Abundant skeletal
muscle markers form characteristic landmark spots [33–35] are
clearly present in our slab gel, such as serum albumin (70.7
kDa/pI 5.8), α-actin (42.4 kDa/pI 5.2), creatine kinase (43.3
kDa/pI 6.6), the two tropomyosin isoforms TPM-1α (32.8 kDa/
pI 4.7) and TPM-2β (32.9 kDa/pI 4.7), and the myosin light
chain (20.7 kDa/pI 5.0). The main protein spot pattern of themdx diaphragm preparation was shown to be relatively
comparable to that from normal control fibre specimens (Fig.
2A, B). Thus, to properly determine potential changes in the
expression levels of individual muscle protein species, we
carried out a densitometric analysis of the two-dimensional spot
pattern and identified proteins via mass spectrometry.
3.3. Two-dimensional immunoblot analysis of luminal
Ca2+-binding proteins in dystrophic diaphragm
To demonstrate that the two-dimensional gel electrophoretic
separation process is suitable for the analysis of Ca2+-binding
proteins from diaphragm muscle, and in order to confirm the
dystrophic status of the mdx preparations, nitrocellulose
replicas of the gels shown in Fig. 2 were immuno-decorated
with established monoclonal antibodies. In analogy to the one-
dimensional immunoblotting presented in Fig. 1, the antibody
staining patterns in Fig. 3 clearly illustrate a reduction in
dystrophin-associated glycoproteins and Ca2+-regulatory ele-
ments in dystrophic mdx muscle. In contrast to the relatively
comparable levels of the surface marker enzyme Na+/K+-
ATPase in normal versus dystrophic specimens (Fig. 3A, F), the
sarcolemmal protein β-dystroglycan (Fig. 3C, H) and its
extracellular binding partner α-dystroglycan (Fig. 3B, G) are
greatly reduced in mdx diaphragm. Since the α/β-dystroglycan
dimer forms the backbone of the dystrophin–glycoprotein
complex by forming an indirect linkage between the extracel-
lular matrix protein laminin and the dystrophin-associated actin
cytoskeleton in healthy muscle fibres, this result clearly
established the dystrophic phenotype of the mdx diaphragm
specimens used in this study. It also demonstrated that two-
dimensional gel electrophoresis is suitable for the comparative
analysis of the protein complement from normal versus
dystrophic diaphragm muscle. The immuno-decoration of two
key Ca2+-binding proteins of the sarcoplasmic reticulum, the
fast CSQf isoform of calsequestrin and sarcalumenin, showed a
Fig. 3. Two-dimensional immunoblot analysis of luminal Ca2+-binding proteins
in mdx diaphragm. Shown are 2D immunoblots focusing on the area of
antibody-decorated protein spots. Blots correspond to the Hot Coomassie-
stained gels in Fig. 2 and were labelled with antibodies to the Na+/K+-ATPase
(NKA; A, F), α-dystroglycan (α-DG; B, G), β-dystroglycan (β-DG; C, H), the
fast CSQf isoform of calsequestrin (D, I), and sarcalumenin (SAR; E, J). Lanes 1
and 2 represent total protein extracts from normal (A–E) and dystrophic mdx
(F–J) diaphragm muscle fibres, respectively.
Fig. 4. Two-dimensional gel electrophoretic reference gel of diaphragm muscle.
Shown is a representative Hot Coomassie-stained 2D gel of total protein extracts
from normal mouse diaphragm muscle. The pH-values of the first dimension gel
system and molecular mass standards (in kDa) of the second dimension are
indicated on the top and on the left of the panels, respectively. Proteins that have
been identified by MALDI-ToF MS tryptic peptide mass fingerprinting from in-
gel digests are marked by circles and are numbered 1 to 50. See Table 1 for a
detailed listing of identified muscle protein species.
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both the major Ca2+-reservoir protein of the terminal cisternae
and the Ca2+-shuttle protein of the longitudinal tubules exhibit
an abnormal density in mdx diaphragm.
3.4. Mass spectrometric fingerprinting of the diaphragm
muscle proteome
As outlined above, two-dimensional gel electrophoresis of
crude tissue preparations under-represents certain protein
species, such as integral membrane proteins, very high-
molecular-mass proteins, low-abundance proteins, and very
acidic proteins. We were therefore not able to determine the
presence of large proteins or tightly membrane-associated
proteins that play an important role in the molecular
pathogenesis of x-linked muscular dystrophy, e.g., the full-
length muscle dystrophin isoform of apparent 427 kDa and the
565 kDa Ca2+-release channel monomer of the skeletal muscle
ryanodine receptor isoform RyR1. The majority of the proteins
seen in the Hot Coomassie-stained gel in Fig. 4 probably
represent mostly soluble protein components of diaphragm
fibres or at least protein species that do not exist in detergent-
insoluble membrane complexes. Image analysis with Amer-
sham Biosciences Imagemaster 2-D Platinium software recog-
nized on this reference gel 333 individual protein spots. Overall,
50 proteins were identified by mass spectrometry (Table 1)
including 20 major protein spots that exhibited a differentialexpression pattern between normal and dystrophic diaphragm.
The expression of 11 of these muscle proteins was decreased in
the mdx mouse model and 9 of them showed an increased
abundance as compared to control mice (Table 2). An additional
30 skeletal muscle marker proteins were identified by mass
spectrometric fingerprinting in order to establish the presence of
landmark protein spots. The unique positioning of these muscle
proteins with their known molecular mass and isoelectric point
demonstrated that our gel electrophoretic separation pattern is
comparable to international 2D-PAGE banks, and that our
experimental protocols sufficiently and reproducibly separated
major protein species of mouse diaphragm muscle.
The results presented in Fig. 4 and Table 1 clearly showed
the presence of key muscle proteins in the two-dimensional
reference gel from normal diaphragm. As outlined above,
landmark spots 5, 19, 23, 30, 33 and 45 represent the highly
abundant muscle proteins serum albumin, α-actin, creatine
kinase, tropomyosin isoform TPM-1α, tropomyosin isoform
TPM-2β and the myosin light chain, respectively. Besides these
contractile proteins and important metabolic factors, less
abundant protein spots corresponded to cellular components
involved in cytoskeleton formation, mitochondrial function,
metabolic control, glycolysis, ion homeostasis, muscle contrac-
tion, and chaperone function. Interestingly, slow-twitch cardiac
isoforms of the myosin β-chain (spot 1) and α-actin (spot 27)
were found to be present in mouse diaphragm muscle,
confirming the special status of diaphragm fibres within the
skeletal muscle group of mammalian tissues. The identified
skeletal muscle markers could be grouped as proteins involved
in contraction (myosin heavy chain/spot 1; actin/spots 19 and
27; tropomyosin/spots 30 and 33; myosin light chain/spots 40,
45 and 47; troponin/spots 41 and 49), mitochondrial enzymes
Table 1
List of identified proteins in 9-week-old mouse diaphragm muscle using mass spectrometry-based proteomics
Spot no. Name of identified protein Sequence coverage (%) Molecular mass (kDa) Isoelectric point (pI) Protein accession no.
1 Cardiac myosin β-heavy chain 10.5 223.66 5.6 gi[16508127]
2 Carbamoyl-phosphate synthase 9.3 166.99 6.4 gi[51705066]
3 Aconitase 2, mitochondrial 8.6 86.22 8.4 gi[13435538]
4 Heat shock 70 kDa protein 5 21.4 72.52 5.0 gi[31981722]
5 Serum albumin precursor 26.0 70.73 5.8 gi[5915682]
6 Serum albumin 23.5 70.73 5.8 gi[3647327]
7 Galactosidase, β1 15.9 73.46 6.9 gi[1730192]
8 RecQ helicase-like protein 15.1 73.50 9.0 gi[46092353]
9 Vimentin 27.5 53.76 5.1 gi[55408]
10 Dihydrolipoamide dehydrogenase 20.4 54.76 8.3 gi[6014973]
11 Desmin 24.9 53.54 5.2 gi[33563250]
12 Atp5b protein 27.0 56.28 5.2 gi[23272966]
13 Vimentin 20.2 51.60 4.9 gi[2078001]
14 Fbxo11 protein 10.4 58.58 6.6 gi[33243977]
15 Aldh2 protein 18.1 57.03 7.7 gi[13529509]
16 Ubiquinol-cytochrome c reductase
core protein 1
14.4 53.46 5.8 gi[46593021]
17 Enolase 3, β-subunit 32.0 47.35 6.7 gi[6679651]
18 Serum albumin, fragment 24.5 53.00 5.5 gi[11277085]
19 Actin (α1) 22.5 42.38 5.2 gi[49864]
20 Creatine kinase, mitochondrial 31.3 47.91 9.1 gi[38259206]
21 Isocitrate dehydrogenase 2 10.0 51.34 9.2 gi[37748684]
22 Unnamed protein product 21.8 42.92 5.6 gi[26342825]
23 Creatine kinase, M chain 18.9 43.26 6.6 gi[6671762]
24 Unnamed protein product 16.1 42.03 9.6 gi[26338608]
25 Aldolase 1, isoform A 27.5 39.75 8.9 gi[44890261]
26 Aspartate aminotransferase 10.7 46.50 6.7 gi[871422]
27 Cardiac α-actin, fragment 18.1 42.05 5.2 gi[627834]
28 2′–5′oligoadenylate synthetase 14.1 43.51 5.5 gi[21326001]
29 Unnamed protein product 9.9 37.37 8.9 gi[12855049]
30 Tropomyosin (TPM-2β) 21.5 32.93 4.7 gi[11875203]
31 Pyruvate dehydrogenase 22.0 39.26 6.4 gi[18152793]
32 Electron transferring flavoprotein,
α-polypeptide
34.2 35.27 8.8 gi[31981826]
33 Tropomyosin (TPM-1α) 33.1 32.75 4.7 gi[20522240]
34 Malate dehydrogenase 24.9 33.63 6.2 gi[319837]
35 Aldehyde reductase 18.2 36.80 6.9 gi[29374169]
36 Glyceraldehyde-3-phosphate
dehydrogenase-like protein
33.6 36.09 8.4 gi[51710824]
37 Regucalcin 37.8 33.90 5.2 gi[6677739]
38 Voltage-dependent anion channel 36.0 30.85 8.8 gi[13786200]
39 Carbonic anhydrase 3 28.1 29.63 6.9 gi[31982861]
40 Myosin light chain 3 54.9 22.52 5.0 gi[33563264]
41 Troponin I, fast muscle TnI-2 37.4 21.51 8.8 gi[6678391]
42 Adenylate kinase 1 31.9 23.33 5.7 gi[10946936]
43 Glutathione S-transferase 15.1 25.91 7.8 gi[33468899]
44 Trioesphosphate isomerase 19.5 22.72 5.6 gi[1864018]
45 Myosin light chain A1 55.9 20.69 5.0 gi[91114]
46 Cryab protein/αB-crystallin 28.0 20.05 6.8 gi[14789702]
47 Myosin light chain 2v 38.0 18.77 4.9 gi[38511915]
48 ATP synthase, mitochondrial 39.8 18.79 5.5 gi[51980458]
49 Troponin C, fast muscle TnC 28.1 18.15 4.1 gi[19354422]
50 Superoxide dismutase 1 31.8 16.10 6.0 gi[45597447]
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lipoamide dehydrogenase/spot 10; pyruvate dehydrogenase/
spot 31), the citric acid cycle (aconitase/spot 3; isocitrate
dehydrogenase/spot 21; malate dehydrogenase/spot 34), oxal-
acetate convertion (aspartate aminotransferase/spot 26), elec-
tron transport (ubiquinol-cytochrome c reductase/spot 16), ATP
synthesis (mitochondrial ATP synthase/spot 48), fatty acid
oxidation (electron transferring flavoprotein/spot 32), andbiosynthesis of pyrimidines (carbamoyl-phosphate synthase/
spot 2), as well as control function of translation (2′–5′-
oligoadenylate synthetase/spot 28), unwinding of double-
helical nucleic acid (RecQ helicase/spot 8), intermediate
filament formation (vimentin/spots 9 and 13; desmin/spot 11),
chaperone function (heat shock protein HSP70/spot 4; cryab
protein/spot 46), fatty acid transportation and protein reservoir
function (albumin/spots 5, 6 and 18), aldehyde metabolism
Table 2
List of identified proteins in 9 week-old mdx mouse diaphragm muscle that
exhibit a change in expression as judged by comparative proteomics
Spot no. Name of identified protein Fold-change +/−
7 Galactosidase, β1 −2.7
9 Vimentin +2.2
10 Dihydrolipoamide dehydrogenase −2.3
11 Desmin +2.1
13 Vimentin +2.6
14 Fbxo11 protein −2.7
15 Aldh2 protein −2.2
18 Serum albumin, fragment +2.8
21 Isocitrate dehydrogenase 2 −2.0
22 Unnamed protein product +2.9
23 Creatine kinase, M chain +3.0
25 Aldolase 1, A isoform +2.0
32 Electron transferring flavoprotein, α-polypeptide +5.7
34 Malate dehydrogenase +3.8
36 Glyceraldehyde-3-phosphate
dehydrogenase- like protein
−5.2
37 Regucalcin −2.0
38 Voltage-dependent anion channel 1 −3.3
42 Adenylate kinase 1 −6.0
47 Cryab protein/αB-crystallin −4.0
48 Myosin light chain 2v −2.4
Fig. 5. Mass spectrometric identification of regucalcin in diaphragm muscle.
Show is the MALDI-ToF spectrum of regucalcin-positive peptides that
identified spot no. 37 in the gel shown in Fig. 4 as a distinct diaphragm muscle
protein. Regucalcin has the SWISS-2DPAGE accession number Q64374
(SM30_MOUSE; gene name RGN/SMP30), the GenBank accession number
D86217 and the protein identification number gi[6677739].
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glycolysis (aldolase/spot 25; enolase/spot 17; glyceraldehyde-3-
phosphate dehydrogenase/spot 36; triosephosphate isomerase/
spot 44), nucleotide metabolism (Atp5b protein/spot 12;
mitochondrial creatine kinase/spot 20; creatine kinase M-
chain/spot 23; adenylate kinase/spot 42), protein ubiquination
(Fbxo11 protein/spot 14), carbohydrate metabolism (galactosi-
dase/spot 7), regulation of acid–base balance (carbonic
anhydrase/spot 39), superoxide radical inactivation (superoxide
dismutase/spot 50), leucotrine metabolism (glutathione S-
transferase/spot 43), and ion homeostasis (regucalcin/spot 37;
voltage-dependent anion channel/spot 38).
3.5. Differential expression of the muscle proteome in normal
versus mdx diaphragm
The differential expression of the diaphragm muscle
proteome in the normal versus the x-linked dystrophic
phenotype is listed in Table 2. Twenty protein spots were
found to exhibit changes in the 1- to 6-fold range, of which
19 could be clearly identified as distinct diaphragm muscle
proteins. Table 2 lists the fold change in density of individual
proteins and gives information on the spot number of these
differentially expressed protein species, so that they can be
correlated to the numbering in Fig. 4. As can be seen in Table
2, major skeletal muscle components such as the intermediate
filament proteins vimentin (spots 9 and 13) and desmin (spot
11), the extracellular fatty acid transport protein albumin (spot
18), creatine kinase (spot 23), the glycolytic enzyme aldolase
(spot 25), the electron transferring flavoprotein (spot 32), and
malate dehydrogenase of the citric acid cycle (spot 34), as
well as an unidentified protein (spot 22), were found to
exhibit increased expression levels in mdx diaphragm. In
stark contrast, 11 diaphragm proteins were identified thatshowed a decreased expression in the mdx mouse model of
Duchenne muscular dystrophy. These were the metabolic
proteins β-galactosidase (spot 7), the enzyme dihydrolipoa-
mide dehydrogenase of the supramolecular pyruvate dehy-
drogenase complex (spot 10), the ubiquination factor Fbxo11
protein (spot 14), aldehyde dehydrogenase (spot 15), isocitrate
dehydrogenase of the citric acid cycle (spot 21), the glycolytic
enzyme glyceraldehydes-3-phosphate dehydrogenase (spot
36), the voltage-dependent anion channel (spot 38), adenylate
kinase (spot 42), the small heat shock protein αB-crystallin/
cryab protein (spot 47), myosin light chain 2v (spot 48), and
regucalcin (spot 37). The differential expression pattern of
creatine kinase and adenylate kinase has been previously
documented. The 6-fold reduction of adenylate kinase in mdx
diaphragm agrees with the recently published proteomics
analysis of mildly dystrophic mdx hind limb by Ge et al. [28],
and shows the reproducibility of comparative approaches that
employ mass spectrometry-based proteomics.
With respect to the calcium hypothesis of x-linked
muscular dystrophy, the most interesting result was the
drastically reduced expression of the cytosolic Ca2+-binding
protein regucalcin with a molecular mass of 33.9 kDa and an
acidic pI-value of 5.2 (spot 37). This protein spot has
previously been identified in two-dimensional liver databases
[34,55] and has the SWISS-2DPAGE accession number
Q64374 (SM30_MOUSE; gene name RGN/SMP30). The
cDNA encoding for regucalcin has the GenBank accession
number D86217 [56]. Fig. 5 shows the results of the tryptic
peptide fingerprint analysis and lists the 10 peptides ranging
from 1057.523 m/z to 2152.055 m/z that clearly identified this
two-dimensional protein spot as regucalcin. This protein,
which is also known as senescence marker protein SMP-30
[50], but referred to as regucalcin in the overwhelming
majority of published papers [49], had not previously been
described in diaphragm muscle fibres. We therefore further
characterized this novel diaphragm protein and investigated
Fig. 6. Two-dimensional immunoblot analysis of the cytosolic Ca2+-binding
protein regucalcin in mdx diaphragm. Shown are Hot Coomassie-stained gels
(A, B) and 2D immunoblots (C, D) that focus on the area of the regucalcin
protein spot in normal (A, C) versus dystrophic mdx (B, D) preparations. Protein
spots in the vicinity of regucalcin correspond to the two tropomyosin isoforms
TPM-1α and TPM-2β, as well as α-actin, pyruvate dehydrogenase (PDH),
malate dehydrogenase (MDH) and aldehyde reductase (AR). Immunoblots were
labelled with antibodies to regucalcin/SMP-30. Panels E and F show the
graphical presentation of the immunoblotting and Coomassie-staining of
regucalcin (n=6; *Pb0.05; **Pb0.01; unpaired students t-test). Lanes 1 and
2 represent preparations from normal controls and dystrophic mdx diaphragm,
respectively.
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immunoblotting.
3.6. Reduced expression of regucalcin in dystrophic mdx
diaphragm muscle as revealed by two-dimensional
immunoblotting
The comparative immunoblotting analysis of regucalcin
expression in normal versus mdx diaphragm, as shown in Fig. 6,Fig. 7. Two-dimensional immunoblot analysis of regucalcin in young and old mdx dia
protein spot in normal (A, F) versus dystrophic mdx (B–E, G–J) diaphragm preparatio
(C, H), 11-month-old (D, I) and 20-month-old (E, J) animals. The immunoblot ana
regucalcin (RC; F–J).clearly confirmed the results from our mass spectrometry-based
proteomics screening. In order to directly compare visually the
findings from the protein labelling analysis and the immuno-
decoration of regucalcin, an enlarged two-dimensional spot
pattern is shown in Fig. 6A, B, and the regucalcin immunoblot
presented in Fig. 6C, D. The proteins constituting the highly
reproducible neighboring 2D spot pattern surrounding regucal-
cin in Hot Coomassie-stained gels of normal mouse skeletal
muscle were shown to be the two tropomyosin isoforms TPM-
2β and TPM-1α on the left side, and α-actin, pyruvate
dehydrogenase, malate dehydrogenase and aldehyde reductase
on the right side (Fig. 6A). Both Hot Coomassie-staining and
immuno-decoration demonstrated that the regucalcin protein
spot is clearly reduced in mdx preparations (Fig. 6A–D). The
graphical presentation of these analyses in Fig. 6E, F shows that
regucalcin expression is approximately 50% reduced in
dystrophin-deficient diaphragm muscle. The lower expression
levels of regucalcin were shown to exist in both young and old
mdx mice. Fig. 7 illustrates the immunoblotting of diaphragm
proteins from 3-week-, 9-week-, 11-month- and 20-month-old
animals. Immuno-decoration of the Na+/K+-ATPase (Fig. 7A–
E) and regucalcin (Fig. 7F–J) showed that in contrast to the
relatively unchanged abundance of the surface ion pump,
regucalcin is clearly reduced in mdx diaphragm muscle at all
stages of the dystrophic degeneration–regeneration cycle. This
is a significant finding with respect to ion homeostasis in
muscular dystrophy, since even small disturbances in cytosolic
Ca2+-buffering may trigger abnormal regulation of Ca2+-
dependent processes that in the long-term might cause muscle
fibre necrosis.
3.7. Reduced expression of regucalcin in mdx diaphragm, heart
and limb muscle
Since Duchenne muscular dystrophy affects, besides the
diaphragm, also the heart and limb muscle, a comparative
immunoblotting survey was performed with all three types of
muscle from 9-week-old mdx mice. Fig. 8 shows the gel
electrophoretic separation of normal versus mdx diaphragm
(Fig. 8A, B), limb muscle (Fig. 8C, D) and heart (Fig. 8E, F).
Comparative immunoblotting of nitrocellulose replicas of these
gels revealed that regucalcin is not only reduced in the
dystrophic diaphragm (Fig. 8G, H), but also in dystrophin-phragm. Shown are immunoblots that focus on the area of the immuno-decorated
ns. The dystrophic specimens were isolated from 3-week-old (B, G), 9-week-old
lysis was carried out with antibodies to the Na+/K+-ATPase (NKA; A–E) and
Fig. 8. Comparative immunoblot analysis of regucalcin in diaphragm, limb muscle and heart. Shown are Deep Purple (A, B, E, F) and Silver (C, D) stained two-
dimensional gels and immunoblots (IB; G–L) that focus on the area of the immuno-decorated protein spot. Panels A, C, E, G, I and K represent normal muscle and
panels B, D, F, H, J and L show dystrophic mdx muscle tissue preparations. The dystrophic specimens were isolated from 9-week-old diaphragm (A, B, G, H), limb
muscle (C, D, I, J) and heart (E, F, K, L). The immunoblot analysis was carried out with an antibody to regucalcin (RC; G–L).
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Thus, the results from the proteomic profiling of the mdx
diaphragm can be extrapolated to limb muscle and cardiac
muscle. This important cytosolic Ca2+-binding protein appears
to be reduced in all three muscle tissues.
4. Discussion
Despite the fact that animal disease models rarely represent
the identical range of clinical symptoms seen in human patients,
the dystrophic mdx mouse is widely employed as a suitable
system for studying molecular and cellular aspects of muscular
dystrophy and to test novel therapeutic approaches [44].
Although the mdx mouse has a milder phenotype, it can be
employed as a good model for studying the effect of dystrophin
deficiency [45]. The mdx diaphragm is especially affected and
exhibits substantial cellular degeneration [42]. Here, we have
separated total diaphragm extracts from normal and dystrophic
mice by two-dimensional gel electrophoresis in order to study
the total muscle complement by mass spectrometry-based
proteomics. Certain technical difficulties exist with comparative
proteomics approaches that use gel electrophoretic separation
techniques. They include an incomplete presentation of certain
integral components, very high molecular mass proteins, low
abundance proteins and very acidic proteins. However,
generally the two-dimensional spot patterns show a large
portion of the soluble muscle protein complement so that it is
possible to detect major changes in protein expression. This
makes the comparative proteomics technique ideal for identi-
fying soluble muscle Ca2+-binding proteins and detect potential
changes in neuromuscular diseases.
The overall two-dimensional protein spot pattern of our
diaphragm preparations compares well with international
databanks and published reports on the electrophoretically
separated skeletal muscle proteome [33–35]. Key spots with a
unique combination of their isoelectric point and relativemolecular mass corresponded to abundant protein species that
were clearly identified by mass spectrometry [34]. The
comparative 2D software analysis revealed drastic changes in
a few protein species, including metabolic enzymes, contractile
proteins, heat shock proteins, cytoskeletal elements and ion-
regulatory proteins. The 6-fold reduction of adenylate kinase in
mdx diaphragm has been previously reported by Ge et al. [28] in
mdx hind limb fibres. Loss of adenylate kinase appears to be
one of the major changes in dystrophin-deficient fibres. Since
the enzymes adenylate kinase and creatine kinase provide a
major nucleotide pathway, the lack of adenylate kinase suggests
an abnormal regulation of nucleotide ratios in mdx diaphragm
and hind limb muscles. The expression of metabolic marker
proteins, such as those involved in glycolysis, the citric acid
cycle, formation of acetyl-coenzyme A, fatty acid transportation
and fatty acid oxidation, was differentially affected. While the
enzymes dihydrolipoamide dehydrogenase, aldehyde dehydro-
genase, glyceraldehyde-3-phosphate dehydrogenase, galactosi-
dase and isocitrate dehydrogenase were reduced, serum
albumin, aldolase and malate dehydrogenase were increased.
This indicates major disturbances in muscle metabolism due to
the loss of key enzymes and the compensatory up-regulation of
other metabolic factors. Possibly, the increased frequency of
micro-rupturing of the dystrophic sarcolemma causes the loss of
the cellular integrity in certain muscle fibres. This in turn may
trigger abnormal fluxes of ions, substrates and co-factors and
thereby impair metabolic pathways. Elevated levels of albumin
in the mdx diaphragm, shown here by proteomics to be
approximately 3-fold, have previously been shown by Dupont-
Versteegden et al. [57]. Skeletal muscle damage appears to be
associated with an influx of extracellular fluid components such
as albumin.
The intermediate filament components desmin and vimentin
were clearly up-regulated in dystrophin-deficient fibres. This
could be interpreted as a compensatory mechanism of the
dystrophic muscle cell in order to rescue its impaired
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constituents of intermediate filaments may strengthen the load-
bearing function of the muscle cytoskeleton. With respect to
muscle diseases related to x-linked muscular dystrophy, the 4-
fold decrease in the small heat shock protein αB-crystallin is
very interesting. Muscular atrophy is characterized by a drastic
decrease in this desmin-associated protein [58] and patients
with mutations in their αB-crystallin gene exhibit progressive
skeletal myopathy and respiratory insufficiency [59]. Thus, the
loss of this protein in dystrophinopathies may be involved in the
down-stream events that render dystrophic muscle fibres more
susceptible to cellular degeneration.
Abnormal Ca2+-handling plays a major role in the molecular
pathogenesis of dystrophinopathies [11–14]. The result from
our proteomics analysis of mdx diaphragm, that the cytosolic
Ca2+-binding protein regucalcin is reduced in dystrophin-
deficient fibres, supports the calcium hypothesis of muscular
dystrophy. In addition to the established increase in sarcolem-
mal Ca2+-leak channels following membrane re-sealing [11],
and the decrease in luminal Ca2+-binding elements sarcalume-
nin and calsequestrin [16,17], the apparent reduction in
regucalcin strongly indicates that abnormal Ca2+-cycling is
involved in mdx fibre degeneration. As reviewed by Yamaguchi
[49,51] and Fujita [50], regucalcin is an abundant regulator of
Ca2+-homeostasis in the liver. The molecular cloning and
sequencing of regucalcin and senescence marker protein SMP-
30, as well as studies on their tissue distribution, by Shimokawa
and Yamaguchi [60,61] and Fujita et al. [62] revealed that both
cytosolic components are identical [49,50]. Regucalcin
enhances the Ca2+-pumping activity in the plasma membrane,
endoplasmic reticulum and mitochondria of various cell types
[63–66], making it an important factor in maintaining low
cytosolic Ca2+-levels [49]. Regucalcin has previously been
shown to be present in liver, kidney, heart and brain [51]. Here,
we can show that it is also expressed in diaphragm and limb
muscle fibres, and that this cytosolic component is abundant
enough to form a distinct Coomassie-stained protein spot in
two-dimensional gels of diaphragm homogenates. The reduc-
tion of regucalcin in both young and old dystrophin-deficient
fibres may trigger a similar degeneration process in the mdx
diaphragm as has been observed during Ca2+-induced cell
degradation in other cell types. Interestingly, the gene for
regucalcin is localized on the X-chromosome [49]. Since
Duchenne muscular dystrophy is an x-linked muscle disease,
with the dystrophin gene being located on the Xp21 region [1], a
fragile x-chromosomal pathology might possibly be involved in
this necrotic process. Reduced regucalcin protein levels in the
mdx mouse could be related to abnormal gene expression
patterns on the affected X-chromosome.
It is surprising that distinct 2D spots in electrophoretically
separated total diaphragm preparations do not represent both
sarcalumenin and calsequestrin. Both Ca2+-binding proteins are
relatively soluble and are major luminal components of the
sarcoplasmic reticulum. Possibly the clustering of calsequestrin
in self-aggregated terminal cisternae units [67], and/or the close
association of calsequestrin with relatively insoluble membrane
proteins of high molecular mass, such as the ryanodine receptorCa2+-release channel of 565 kDa [68] or triadin oligomers of
above 2,000 kDa [69], might prevent a sufficient extraction
prior to gel electrophoresis [70]. The close interaction between
sarcalumenin and the integral Ca2+-ATPase tetramers of the
longitudinal tubules [16] might mean that sarcalumenin
molecules are difficult to solubilize. It is well known that
integral membrane proteins and proteins that exist in vivo as
large protein complexes are under-represented in two-dimen-
sional gels from total tissue extracts. Hence, abundant and
soluble proteins that are closely linked to insoluble protein
species might not be properly extracted from tissue homo-
genates or may fail to enter the first or second dimension gel
system. Both calsequestrin and sarcalumenin appears to fall into
this category of muscle proteins. However, despite the fact that
we were unable to identify luminal Ca2+-binding proteins via
mass spectrometry, the immuno-decoration of both proteins
confirmed their drastic reduction in dystrophic fibres, including
diaphragm muscle.
In conclusion, the comparative proteomics screening of
normal versus mdx diaphragm led to the identification of the
cytosolic Ca2+-binding element regucalcin in skeletal muscle.
The 2-fold reduction of this Ca2+-regulatory protein in
dystrophin-deficient muscle fibres agrees with the concept
that abnormal Ca2+-handling is involved in x-linked muscular
dystrophy. Since Ca2+-cycling through the cytosol of muscle
fibres represents a crucial second messenger system involved in
the regulation of various metabolic and physiological processes
[71], any disturbances of ion fluxes between the contractile
apparatus, metabolic complexes, the transverse tubules, the
sarcoplasmic reticulum, the sarcolemma and mitochondria may
trigger fibre degeneration. Since the amount of cytosolic Ca2+-
ions dictates the overall contractile status of skeletal muscle
fibres, Ca2+-cycling through intracellular reservoirs has to be
maintained under precise spatial and temporal control. There-
fore, the drastic reduction in luminal and cytosolic Ca2+-binding
proteins may render dystrophic muscle fibres more susceptible
to necrosis. Probably, a causal connection exists between
sarcolemmal disintegration, caused primarily by the deficiency
in dystrophin, and the Ca2+-dependent proteolysis of key
muscle proteins [11]. The destabilization of the dystroglycan-
mediated linkage between the extracellular matrix and the
membrane cytoskeleton seems to cause an influx of extracel-
lular Ca2+-ions via membrane re-sealing. The pathophysiolog-
ical consequence of increased Ca2+-fluxes into the fibre interior
is then exacerbated by the decreased availability of the cytosolic
Ca2+-binding element regucalcin and the impaired Ca2+-
buffering capacity of the sarcoplasmic reticulum in dystrophic
fibres. This molecular scenario of abnormal ion handling in
dystrophin-deficient fibres suggests that the therapeutic inter-
vention on the level of Ca2+-homeostasis [72,73] might be a
useful option to explore in the development of novel treatment
strategies for Duchenne muscular dystrophy.
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